New Drug Treats Pulmonary Arterial Hypertension

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 114, Nº. 2, 2014, págs. 24-25
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * A new endothelin-receptor blocker, macitentan (Opsumit), has been approved for the treatment of pulmonary arterial hypertension.

    * The drug may produce severe fetal disorders and cannot be used during pregnancy. Women of childbearing age are required to receive the drug through a special restrictive program.

    * Nurses should confirm that female patients are not pregnant prior to the start of therapy and that they understand the need for adherence to specific birth control measures.